Header cover image

Swiss (SMI) Healthcare Sector Analysis

UpdatedJul 29, 2025
DataAggregated Company Financials
Companies35
  • 7D2.4%
  • 3M1.1%
  • 1Y-3.0%
  • YTD4.2%

In the last week, the Healthcare industry is up 1.2%, with Roche Holding up 2.0%. However, the industry is down 3.2% over the past year. Earnings are forecast to grow by 14% annually.

Sector Valuation and Performance

Has the Swiss Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 29 Jul 2025CHF 603.3bCHF 153.6bCHF 24.2b31.2x24.9x3.9x
Thu, 26 Jun 2025CHF 581.3bCHF 150.4bCHF 22.3b30.2x26x3.9x
Sat, 24 May 2025CHF 573.6bCHF 151.6bCHF 22.5b30.5x25.5x3.8x
Mon, 21 Apr 2025CHF 545.7bCHF 149.9bCHF 21.8b25.9x25.1x3.6x
Wed, 19 Mar 2025CHF 628.4bCHF 154.5bCHF 22.4b31.7x28.1x4.1x
Fri, 14 Feb 2025CHF 637.4bCHF 156.2bCHF 22.4b30.3x28.4x4.1x
Sun, 12 Jan 2025CHF 589.7bCHF 153.5bCHF 24.7b30.1x23.9x3.8x
Tue, 10 Dec 2024CHF 569.9bCHF 150.6bCHF 24.2b29x23.6x3.8x
Thu, 07 Nov 2024CHF 590.5bCHF 150.3bCHF 24.1b29.8x24.5x3.9x
Sat, 05 Oct 2024CHF 598.9bCHF 148.0bCHF 22.5b32.9x26.6x4x
Mon, 02 Sep 2024CHF 631.7bCHF 147.3bCHF 22.4b32.7x28.3x4.3x
Wed, 31 Jul 2024CHF 617.1bCHF 149.4bCHF 22.6b31.4x27.3x4.1x
Fri, 28 Jun 2024CHF 577.4bCHF 149.0bCHF 22.7b35.3x25.4x3.9x
Sun, 26 May 2024CHF 557.3bCHF 150.2bCHF 22.9b33.6x24.3x3.7x
Tue, 23 Apr 2024CHF 539.2bCHF 145.0bCHF 22.3b35.3x24.2x3.7x
Thu, 21 Mar 2024CHF 535.4bCHF 143.5bCHF 22.2b37.8x24.2x3.7x
Sat, 17 Feb 2024CHF 520.7bCHF 142.8bCHF 22.4b32.9x23.3x3.6x
Mon, 15 Jan 2024CHF 544.6bCHF 151.4bCHF 21.8b27.5x25x3.6x
Wed, 13 Dec 2023CHF 525.1bCHF 153.1bCHF 22.0b25.6x23.9x3.4x
Fri, 10 Nov 2023CHF 505.7bCHF 154.8bCHF 22.1b23.6x22.8x3.3x
Sun, 08 Oct 2023CHF 532.1bCHF 154.5bCHF 21.8b28.2x24.4x3.4x
Tue, 05 Sep 2023CHF 543.9bCHF 144.2bCHF 21.1b29.9x25.8x3.8x
Thu, 03 Aug 2023CHF 556.7bCHF 146.9bCHF 22.5b35.8x24.7x3.8x
Sat, 01 Jul 2023CHF 565.9bCHF 147.1bCHF 22.2b35.6x25.5x3.8x
Mon, 29 May 2023CHF 579.0bCHF 147.7bCHF 22.3b35x26x3.9x
Wed, 26 Apr 2023CHF 596.4bCHF 146.4bCHF 22.3b34.1x26.7x4.1x
Fri, 24 Mar 2023CHF 530.2bCHF 147.7bCHF 22.5b30.9x23.6x3.6x
Sun, 19 Feb 2023CHF 547.3bCHF 148.0bCHF 22.7b32.2x24.1x3.7x
Tue, 17 Jan 2023CHF 575.8bCHF 148.5bCHF 38.1b31.7x15.1x3.9x
Thu, 15 Dec 2022CHF 581.9bCHF 148.4bCHF 38.0b31.7x15.3x3.9x
Sat, 12 Nov 2022CHF 584.0bCHF 149.5bCHF 38.4b30.8x15.2x3.9x
Mon, 10 Oct 2022CHF 565.5bCHF 152.8bCHF 40.6b27.3x13.9x3.7x
Wed, 07 Sep 2022CHF 582.2bCHF 152.1bCHF 40.4b24.8x14.4x3.8x
Fri, 05 Aug 2022CHF 602.7bCHF 149.7bCHF 39.7b32.2x15.2x4x
Price to Earnings Ratio

15.2x


Total Market Cap: CHF 602.7bTotal Earnings: CHF 39.7bTotal Revenue: CHF 149.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Healthcare Sector Price to Earnings3Y Average 23.4x202320242025
Current Industry PE
  • Investors are relatively neutral on the Swiss Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 23.4x.
  • The industry is trading close to its 3-year average PS ratio of 3.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 15% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare sector?

CH Market-0.19%
Healthcare2.42%
Biotech8.82%
Life Sciences3.55%
Medical Equipment2.70%
Pharma2.27%
Healthtech0.39%
Healthcare Services-2.23%
Industry PE
  • Investors are most optimistic about the Life Sciences industry, which is trading close to its 3-year average PE ratio of 44.8x.
    • Analysts are expecting annual earnings growth of 19.2%, which is lower than the prior year's growth of 34.9% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 35% over the next 5 years.
  • This is better than its past earnings decline of 79% per year.
  • In contrast, the Biotech industry is expected to see its earnings decline by 10% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ROG Roche HoldingCHF 260.602.0%
+CHF 18.0b
-8.7%PE23.5x
NOVN NovartisCHF 93.342.0%
+CHF 3.5b
-4.8%PE16.5x
GALD Galderma GroupCHF 133.705.9%
+CHF 1.8b
99.6%PE104.5x
ALC AlconCHF 72.724.0%
+CHF 1.4b
-12.3%PE40.1x
BANB Bachem HoldingCHF 72.6525.3%
+CHF 1.1b
-5.9%PE45.3x

Latest News